Skip Content
You are currently on the new version of our website. Access the old version .

COVID, Volume 2, Issue 11

2022 November - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Review
  • Open Access
7 Citations
6,044 Views
16 Pages

Inflammation in COVID-19: A Risk for Superinfections

  • Mariana Boulos,
  • Tamara Bassal,
  • Asad Layyous,
  • Maamoun Basheer and
  • Nimer Assy

18 November 2022

The worldwide coronavirus pandemic has been one of the most significant health crisis threats in recent years. COVID-19 has not been the only cause of mortality in this pandemic. A dangerous but frequent complication of viral infections is secondary...

  • Article
  • Open Access
3 Citations
4,232 Views
15 Pages

Caregiver and Youth Mental Health during COVID-19: Risk and Resilience Factors in a Large National Sample in Peru

  • July Caballero-Peralta,
  • Daniel A. Antiporta,
  • Yuri Cutipé,
  • Rocío Vargas-Machuca,
  • Carlos Rojas,
  • Carla Cortez-Vergara,
  • Johann M. Vega-Dienstmaier,
  • Talia S. Benheim,
  • Anamika Dutta and
  • J. Michael Murphy
  • + 3 authors

12 November 2022

The present study examined the prevalence and correlates of psychosocial impairment in a large, national sample of Peruvian children and adolescents (ages 5.0–17.9) during the COVID-19 pandemic in late 2020. A sample of 8263 online questionnair...

  • Brief Report
  • Open Access
1 Citations
3,166 Views
10 Pages

Follow-up of Interleukin 6 and Other Blood Markers during the Hospitalization of COVID-19 Patients: A Single-Center Study

  • Maritza P. Garrido,
  • Varsha Vaswani,
  • Katherinne Contreras,
  • Marcela Barberán,
  • Manuel Valenzuela-Valderrama,
  • Diana Klajn,
  • Carmen Romero,
  • María Jesús Vial Covarrubias and
  • Rodrigo Alfredo Cornejo

10 November 2022

COVID-19 is a recent respiratory illness with high morbidity and mortality; therefore, the study and characterization of blood markers associated with the improvement or deterioration of COVID-19 patients are crucial. This study compared levels of in...

  • Article
  • Open Access
1,748 Views
9 Pages

Frequency of Positive Results for SARS-CoV-2 Infection in Symptomatic Pediatric Patients Treated in the Emergency Department of a Regional Hospital

  • Gabriela Fernanda López,
  • Andreu Fenollosa,
  • Victoria Wolter,
  • Pau Satorra,
  • Carlos Pérez-López and
  • Alejandro Rodríguez-Molinero

9 November 2022

Objectives: Since 11 March 2020, when the World Health Organization declared the COVID-19 pandemic, trials have found that the pediatric population is the least affected, and most positive cases are asymptomatic or have mild symptoms such as fever an...

  • Article
  • Open Access
2,186 Views
11 Pages

Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants?

  • Alessandro Ferrari,
  • Irene Cassaniti,
  • Antonella Sarasini,
  • Daniele Lilleri,
  • Josè Camilla Sammartino,
  • Claudia Del Fante,
  • Fausto Baldanti,
  • Elena Percivalle and
  • Cesare Perotti

31 October 2022

Background and Objectives: New SARS-CoV-2 variants may impact the effectiveness of previously stored convalescent plasma (CCP). We defined levels of anti-delta and anti-omicron SARS-CoV-2 neutralizing antibodies (Nt-Abs) and investigated possible dif...

  • Article
  • Open Access
5 Citations
4,133 Views
13 Pages

Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection

  • Sun-Young Lim,
  • Zhiru Guo,
  • Ping Liu,
  • Lindsay G. A. McKay,
  • Nadia Storm,
  • Anthony Griffiths,
  • Ming Da Qu,
  • Robert W. Finberg,
  • Mohan Somasundaran and
  • Jennifer P. Wang

28 October 2022

Coronavirus disease 2019 (COVID-19) has had devastating effects worldwide, with particularly high morbidity and mortality in outbreaks on residential care facilities. Amantadine, originally licensed as an antiviral agent for therapy and prophylaxis a...

  • Article
  • Open Access
2 Citations
4,532 Views
13 Pages

A Response to the COVID-19 Pandemic: Experience of the University of Botswana

  • Benjamin Bolaane,
  • Richie Moalosi,
  • Yaone Rapitsenyane,
  • Monageng Kgwadi,
  • Venkata Kommula and
  • Jerekias Gandure

26 October 2022

The outbreak of COVID-19 presented many challenges to the global community. The scientific community developed vaccines to mitigate the virus spread and morbidity. Higher Education institutions shifted their research and development activities toward...

  • Article
  • Open Access
7 Citations
2,676 Views
20 Pages

24 October 2022

Governments are seeking to slow the spread of COVID-19 by implementing measures that encourage, or mandate, changes in people’s behaviour such as the wearing of face masks. The success of these measures depends on the willingness of individuals...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
COVID - ISSN 2673-8112